
Interparfums (IPAR) has seen mixed recent returns, with the stock down around 6% over the past month but up roughly 13% in the past 3 months. This has prompted fresh interest in its fragrance focused business.
See our latest analysis for Interparfums.
Looking beyond the recent 6% 30 day share price pullback, Interparfums still has a 13.4% 90 day share price return, although the 1 year total shareholder return of a 25% decline shows longer term holders are still under water.
If this price reset has you comparing fragrance and beauty names with other quality businesses, it could be worth broadening your search to our 20 top founder-led companies.
With the shares pulling back over 1 year, but recent 90 day returns in positive territory and an indicated 51% intrinsic discount, the key question is simple: is Interparfums now undervalued, or is the market already pricing in future growth?
Interparfums' most followed valuation narrative places fair value at $111.20 versus the last close of $93.90. This frames a meaningful gap that hinges on how its fragrance licenses and brand portfolio play out over time.
Ongoing portfolio expansion with prestigious fragrance licenses (e.g., recent additions like Longchamp and growth with Lacoste and Solférino) enhances brand diversity and secures access to rising demand for premium and experiential luxury products, supporting future top-line growth and earnings stability.
Curious what kind of revenue climb, margin profile, and future earnings multiple are embedded in that valuation gap? The full narrative outlines the growth path and the pricing power assumptions behind that $111.20 fair value anchor.
Result: Fair Value of $111.20 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, this story can change quickly if key fragrance licenses underperform or are not renewed, or if retailer destocking weighs more heavily on future sales.
Find out about the key risks to this Interparfums narrative.
While the narrative fair value of $111.20 points to Interparfums being 15.6% undervalued, the P/E story is less generous. The shares trade on 17.9x earnings versus a fair ratio of 15.2x, even though that 17.9x is lower than both peers at 52.9x and the global personal products average at 20.5x. This raises the question of whether this represents a margin of safety or a sign that expectations already carry some optimism.
See what the numbers say about this price — find out in our valuation breakdown.
Given the mixed signals in the story so far, this is a good moment to look through the numbers yourself and decide what matters most to you. To balance the concerns and the potential upside, take a close look at the 3 key rewards and 1 important warning sign so you can weigh both sides before you move on.
If Interparfums has you rethinking what belongs in your portfolio, do not stop here. A few minutes with a focused screener could change your shortlist.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com